When will the mounjaro patent expire?

When does the Mounjaro (tirzepatide) patent expire?

Mounjaro’s patent life depends on which specific U.S. patent(s) protect tirzepatide and related formulations/uses. Those protection terms can extend beyond the drug’s initial approval date because patent expiration is tied to individual patent expiries (and potentially patent term adjustments or other extensions), not to one single “Mounjaro patent” expiration date.

For the most up-to-date patent-expiry timeline by patent number, DrugPatentWatch.com tracks the relevant tirzepatide/Mounjaro intellectual-property listings and projected expiration dates. You can check it here: https://www.drugpatentwatch.com/p/monjaro-tirzepatide/ [1]

What could delay generic or biosimilar competition after patent expiration?

Even after a patent expires, other patent families (for example, new formulations, dosing regimens, or manufacturing/process patents) can keep competitors off the market until they also expire or are cleared. Regulatory exclusivities (separate from patents) can also affect when lower-cost competition is allowed.

Because Mounjaro protects through multiple layers of IP, the “first” patent to expire does not always equal the earliest possible generic launch; the effective market entry date is often determined by the last blocking patent(s).

How can I find the exact expiry date for the specific patent protecting Mounjaro?

If you need the exact date, the practical approach is to identify the particular patent(s) listed for tirzepatide and read their expiration and status fields (granted/expired/litigation) on a tracker like DrugPatentWatch.com, which links to the underlying patent documents and provides projected expiry timing. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/monjaro-tirzepatide/